Clinical Trials Logo

Clinical Trial Summary

This trial will consist of a clinical series of up to 50 children with Global Developmental Delay and concomitant microcephaly or hyperkinetic movements. All children will be assessed for psychomotor function using standardized assessments, goal specific assessments, with the potential addition of neuroimaging assessment, prior to and after receiving an intensive burst of neuromotor therapy. The interventional effects will be explored by comparing the pre and post interventional assessments and neuroimaging.


Clinical Trial Description

Up to 50 children between the ages of 6 months and 15 years will be recruited to participate in a burst of intensive neuromotor intervention in the form of Acquire therapy, delivered by the treatment team at Virginia Tech's Neuromotor Research Clinic. All children will have a diagnosis of Global Developmental Delay, with concomitant microcephaly or hyperkinetic movements. The children will be assessed for psychomotor function prior to and after the treatment intervention, using a series of standardized and goal specific assessments, with the possibility of additional neuroimaging assessments when possible. Acquire therapy is an intensive intervention in that it is delivered with high intensity, wherein goal directed behaviors are promoted at high levels of repetition and delivered at a high dose (4-6 hours a day) in an intensive burst of 3-4 weeks of 5 day a week treatment. Acquire therapy is an operant conditioning based intervention delivered in a cycle of refinement, reinforcement and repetition. It is play-based with activities selected to drive behavior toward goals that are specific to each child and selected based on each child's interests and needs. As such a specific protocol cannot be outlined. However, all goal directed activities are designed to promote awareness of and engagement with others and the environment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04816175
Study type Interventional
Source Virginia Polytechnic Institute and State University
Contact
Status Completed
Phase N/A
Start date April 30, 2019
Completion date August 11, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT02510170 - Fetal and Maternal Head Circumference During Pregnancy in Israeli Population N/A
Completed NCT01565005 - Microcephaly Genetic Deficiency in Neural Progenitors N/A
Terminated NCT03922594 - Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia
Recruiting NCT06019182 - MEHMO Natural History and Biomarkers
Completed NCT02943304 - Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
Completed NCT03330600 - Efficacy of Aquatic Physiotherapy in Children With Microcephaly by Zika Virus Congenital Syndrome N/A
Recruiting NCT03255369 - Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF)
Recruiting NCT03325946 - The FBRI VTC Neuromotor Research Clinic
Completed NCT02741882 - Zika and Microcephaly: Case-control Study N/A
Recruiting NCT05518188 - Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) Phase 1/Phase 2
Recruiting NCT03651687 - Guangzhou Surveillance and Clinical Study in Microcephaly (GSCSM)
Completed NCT00001639 - Evaluation of Patients With Unresolved Chromosome Abnormalities N/A
Withdrawn NCT01151462 - Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.
Completed NCT05322980 - Summary of Infants Weighing 500 Grams or Less